Fetal Valproate Syndrome – A Case Report | Zendy

Derya Kalyoncu | Zendy; Ümran Çetinçelik | Zendy; Feyzullah Çetinkaya | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Fetal Valproate Syndrome – A Case Report

Author(s) -

Derya Kalyoncu,

Ümran Çetinçelik,

Feyzullah Çetinkaya

Publication year - 2018

Publication title -

advances in neurology and neuroscience

Language(s) - English

Resource type - Journals

ISSN - 2690-909X

DOI - 10.33140/an.01.01.03

Subject(s) - valproic acid , medicine , pregnancy , in utero , fetus , autism spectrum disorder , facial dysmorphism , epilepsy , pediatrics , autism , psychiatry , chemistry , biology , biochemistry , genetics , gene , phenotype

Background: Fetal Valproate Syndrome (FVS) results from prenatal exposure to valproic acid (VPA).Case characteristics: A four year old female child presented with facial dysmorphism and features of autism spectrumdisorder (ASD). She had in-utero exposure to valproic acid (VPA).Message: VPA to be avoided in pregnancy and in Dysmorphism or ASD children maternal anti- convulsant drug historymust be taken.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research